Tag Archive: Mulchandani-Bhoj-Conlin Syndrome

Dec 27 2017

Our Most Read Stories of 2017 Bring Back the Wonder of Childhood

It was a big year for children’s health: We celebrated the U.S. Food and Drug Administration’s approval of the world’s first chimeric antigen receptor (CAR)-T cell therapy this September, followed closely by approval of the very first gene therapy to treat inherited blindness this month — both of which have their roots at Children’s Hospital of Philadelphia and the University of Pennsylvania. But besides the big headline-making breakthroughs (brilliant as they are), we wanted to know what other stories captivated our readers in 2017.

Read the rest of this entry >>

Apr 7 2017

Nursing Research Recognition, CAR T-Cell Therapy, Stand Up to Cancer Grant, Neuropsychiatric Disorders in Lupus, Newly Named Genetic Disorder

CHOP Research In the News“Bold” is perhaps the best word to describe this week’s roundup of Research Institute news, as Children’s Hospital of Philadelphia nurses and investigators alike made headlines for their experimental work in pediatric CAR T-cell therapy.

Read the rest of this entry >>